Graf Akcie TEVA (Teva- Pharmaceutical Industries Ltd.). Diskuze k akciím TEVA. Aktuální informace TEVA.

Základní informace o společnosti Teva- Pharmaceutical Industries Ltd. (Akcie TEVA)

Skvělé pro velmi rychlou analýzu společnosti. Investor může porovnat různé ukazatele s konkurenčními firmami.

Tržní kapitalizace 10.86B
Hodnota podniku (EV) 32.18B
Tržby 16.323B
EBITDA 4.583B
Zisk -3.92
Růst v tržbách Q/Q 1.03 %
Růst v tržbách Y/Y -0.96 %
P/E (Cena vůči ziskům) N/A
Forward P/E N/A
EV/Sales 1.97
EV/EBITDA 7.02
EV/EBIT N/A
PEG 0.79
Price/Sales 0.67
P/FCF N/A
Price/Book 1.08
Účetní hodnota na akcii 8.96
Hotovost na akcii 1.95
FCF vůči ceně -1.62 %
Počet zaměstnanců 37,736
Tržba na zaměstnance 432.558k
Profit margin -23.95 %
Operating margin -18.29 %
Gross margin 46.38 %
EBIT margin -17.21 %
EBITDA margin 28.08 %
EPS - Zisk na akcii N/A
EPS - Kvartální růst 7.27 %
EPS - Očekávaný růst příští rok 12.07 %
Return on assets -7.89 %
Return on equity -39.21 %
ROIC -6.27 %
ROCE -7.70 %
Dluhy/Equity 3.95
Čistý dluh/EBITDA 20.80
Current ratio 1.01
Quick Ratio 0.67
Volatilita 3.02
Beta 0.74
RSI 52.58
Cílová cena analytiků 12
Známka akcie (dle analytiků) 2.71
Insider ownership 0.78 %
Institutional ownership 52.21 %
Počet akcií 1.103B
Procento shortovaných akcií 0.00 %
Short ratio 4.04 %
Dividenda 0.00
Procentuální dividenda 0.00 %
Dividenda/Zisk 0.00 %
Obchodovaná od 1982
Země Israel

Finanční výsledky akcie TEVA

Finanční výsledky společnosti, napoví investorovi, zda se jedná o kvalitní společnost.

# 2020 2019 2018 2017 2016 2015
Revenue$16,659$16,887$18,271$22,385$21,903$19,652
Cost Of Goods Sold$8,933$9,351$9,975$11,770$10,044$8,296
Gross Profit$7,726$7,536$8,296$10,615$11,859$11,356
Research And Development Expenses$997$1,010$1,213$1,778$2,111$1,525
SG&A Expenses$3,671$3,806$4,214$4,846$5,145$4,838
Other Operating Income Or Expenses$-20$-1,102$1,499$699$-130$-465
Operating Expenses$14,100$15,692$14,890$36,631$19,749$16,300
Operating Income$2,559$1,195$3,381$-14,246$2,154$3,352
Total Non-Operating Income/Expense$-6,964$-2,461$-5,977$-4,133$-1,330$-1,000
Pre-Tax Income$-4,406$-1,265$-2,596$-18,379$824$2,352
Income Taxes$-168$-278$-195$-1,933$521$634
Income After Taxes$-4,238$-987$-2,401$-16,446$303$1,718
Other Income------
Income From Continuous Operations$-4,100$-1,000$-2,472$-16,449$311$1,597
Income From Discontinued Operations------
Net Income$-3,990$-999$-2,399$-16,525$68$1,573
EBITDA$4,116$2,917$5,223$-12,134$3,678$4,660
EBIT$2,559$1,195$3,381$-14,246$2,154$3,352
Basic Shares Outstanding1,0951,0911,0211,016955855
Shares Outstanding1,0951,0911,0211,016961864
Basic EPS$-3.64$-0.91$-2.35$-16.26$0.07$1.84
EPS - Earnings Per Share$-3.64$-0.91$-2.35$-16.26$0.07$1.82
# 2020 2019 2018 2017 2016 2015
Current Ratio0.98790.98460.96310.85830.93181.4147
Long-term Debt / Capital0.67270.61990.62830.6060.48170.2183
Debt/Equity Ratio2.34331.78631.83081.73251.02310.3322
Gross Margin46.377344.63245.405347.420254.143357.7855
Operating Margin15.36117.076518.5047-63.64089.834317.0568
EBIT Margin15.36117.076518.5047-63.64089.834317.0568
EBITDA Margin24.707417.273628.5863-54.205916.792223.7126
Pre-Tax Profit Margin-26.4482-7.491-14.2083-82.10413.76211.9683
Net Profit Margin-23.951-5.9158-13.1301-73.82180.31058.0043
Asset Turnover0.3290.29380.30110.3170.23540.3624
Inventory Turnover Ratio2.02882.11472.10842.39032.02752.0918
Receiveable Turnover3.63652.97523.13833.14042.91153.6733
Days Sales In Receivables100.3701122.6825116.3062116.226125.366299.3665
ROE - Return On Equity-37.0638-6.6388-15.6515-108.83290.99135.9956
Return On Tangible Equity22.1794.758510.688360.2329-1.006449.4887
ROA - Return On Assets-8.0964-1.74-4.0736-23.29390.33422.9447
ROI - Return On Investment-12.1331-2.5237-5.8173-34.57560.46064.1713
Book Value Per Share10.092213.79414.489918.431734.475932.9593
Operating Cash Flow Per Share0.4249-1.71010.2057-3.247-0.97740.4389
Free Cash Flow Per Share0.125-2.111-2.1222-1.83070.45541.0061

Porovnání s konkurencí: Akcie TEVA

Společnost P/E PEG Růst v tržbách (roční) Růst v EPS Return on equity P/B Profit margin
TEVA N/A 0.79 -0.96 % 12.07 % -39.21 % 1.08 -23.95 %
Akcie AZN 41.82 1.02 14.90 % 40.43 % 26.02 % 10.19 11.81 %
Akcie GSK 16.60 3.36 N/A % -14.00 % 29.69 % 4.85 16.86 %
Akcie MRK 35.60 1.38 2.87 % 13.14 % 19.42 % 7.90 14.72 %
Akcie MYL 32.42 0.68 1.11 % -2.86 % 2.25 % 0.72 N/A %
Akcie PFE 17.66 1.97 4.96 % 50.00 % 19.81 % 3.72 22.95 %

Nedávné obchody insiderů: Akcie TEVA

Jméno Obchod Cena Objem
Eric Drape
Executive VP Global Operations
Prodej
9 Feb 2021
$12.72 $228,693
Hafrun Fridriksdottir
Executive VP, Global R, and D
Prodej
9 Feb 2021
$12.69 $374,304
Gianfranco Nazzi
EVP and International Markets
Prodej
9 Feb 2021
$12.72 $275,197
Mark Sabag
See "Remarks" below
Option
9 Feb 2021
$12.81 $198,850
Kare Schultz
President and CEO
Option
9 Feb 2021
$12.81 $344,166
David Matthew Stark
Exec. VP Chief Legal Officer
Prodej
9 Feb 2021
$12.69 $828,809
Eric Drape
Executive VP Global Operations
Option
14 Feb 2021
$11.12 $43,657
Hafrun Fridriksdottir
Executive VP, Global R, and D
Option
14 Feb 2021
$11.12 $59,548
Mark Sabag
See "Remarks" below
Option
14 Feb 2021
$11.12 $63,517
David Matthew Stark
Exec. VP Chief Legal Officer
Option
14 Feb 2021
$11.12 $43,657

Diskuze k akciím TEVA